Colorectal cancer organoids
Cellesce has initially focused on colorectal cancer organoids that reflect the genetic diversity found in the major colorectal cancer sub-types. Full gene sequencing, RNA expression and drug response data will be provided for each organoid. These will be available in commercial quantities from early 2017. For more information or to pre-order please contact us.
Organoids of other human organs
Cellesce will provide organoids of other human tissues such as breast, liver, lung and prostate from 2018. If you have developed organoids and would like to partner with Cellesce to offer these commercially please contact us.